Search results
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks via Yahoo Finance· 7 hours agoModerna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 4 hours agoShares of Moderna, Inc. MRNA were down 4.4% on May 10 after the company announced that the FDA has...
While shareholders of Moderna (NASDAQ:MRNA) are in the black over 5 years, those who bought a week...
Simply Wall St. via Yahoo Finance· 6 hours agoLong term investing can be life changing when you buy and hold the truly great businesses. And we've...
Moderna: FDA Extends RSV Vaccine Review, But No Issues Flagged
Morningstar· 3 days agoModerna on Friday said the Food and Drug Administration won't meet its May 12 target action date for a decision on the company's proposed vaccine for respiratory syncytial ...
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 14 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. Following ...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 1 day agoModerna (NASDAQ: MRNA) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 4 hours agoModerna Inc (MRNA, Financial) has recently shown a notable daily gain of 5.55%, with a three-month gain of 34.21%. Despite these impressive numbers, a deeper look into the ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 7 hours agoThough it might be tempting to invest in stocks that have largely been in tandem with the broader...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 9 hours agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...